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Generation of amyloid β peptides (Aβs) by proteolytic cleavage of the amyloid 
precursor protein (AβPP), especially increased production of Aβ42/Aβ43 over Aβ40, and their 
aggregation as oligomers and plaques, represent a characteristic feature of Alzheimer’s disease 
(AD). In familial AD (FAD), altered Aβ production originates from specific mutations of AβPP 
or presenilins 1/2 (PS1/PS2), the catalytic subunits of γ-secretase. In sporadic AD, the origin of 
altered production of Aβs remains unknown. We hypothesize that the ‘human chemical 
exposome’ contains products able to favor the production of Aβ42/Aβ43 over Aβ40 and shorter 
Aβs. To detect such products we screened a library of 3500+ compounds in a cell-based assay 
for enhanced Aβ42/Aβ43 production. Nine pyrazole insecticides were found to induce a β- and 
γ-secretase-dependent, 3-10 fold increase in the production of extracellular Aβ42 in various cell 
lines and neurons differentiated from induced pluripotent stem cells derived from healthy and 
FAD patients. Immunoprecipitation/mass spectrometry analyses showed increased production 
of As cleaved at positions 42/43, and reduced production of peptides cleaved at positions 38 
and shorter. Strongly supporting a direct effect on -secretase activity, pyrazoles shifted the 
cleavage pattern of another γ-secretase substrate, alcadeinα, and shifted the cleavage of AβPP 
by highly purified γ-secretase towards Aβ42/Aβ43. Focusing on fipronil, we showed that some 
of its metabolites, in particular the persistent fipronil sulfone, also favor the production of 
Aβ42/Aβ43 in both cell-based and cell-free systems. Fipronil administered orally to mice and rats 
is known to be metabolized rapidly, mostly to fipronil sulfone, which stably accumulates in 
adipose tissue and brain. In conclusion, several widely used pyrazole insecticides enhance the 
production of toxic, aggregation prone Aβ42/Aβ43 peptides, suggesting the possible existence of 
environmental “Alzheimerogens” which may contribute to the initiation and propagation of the 
amyloidogenic process in sporadic AD.  
 
  






 Alzheimer’s disease (AD) is a major disease in countries with aging populations. 
Despite unresolved questions on the initial causes of AD and numerous clinical trial failures in 
recent years, the lack of satisfactory treatments and the extremely high prevalence of AD calls 
for fundamental research to determine its underlying molecular and cellular causes and 
mechanisms and for applied research to identify options for prevention, therapeutic targets and 
disease-modifying drug candidates [reviews in 1-4].  
 Although the aggregation of specific forms of amyloid β peptides (Aβs) into soluble 
oligomers is undoubtedly associated with the onset of AD, the upstream etiological events 
underlying this pathological process remain unclear, including whether there is an absolute, or 
relative, increase in the production of longer aggregation-prone Aβ species. Aβs are derived 
from the successive action of two proteases, β-secretase and γ-secretase on one of their 
numerous substrates, the transmembrane Amyloid precursor protein (AβPP). According to its 
cleavage site γ-secretase liberates Aβs of different sizes. While Aβ40 is considered as the main 
physiological product, the appearance of Aβ42 and Aβ43, or increase of the Aβ42-Aβ43/Aβ40 
ratio is clearly associated with the onset of AD [5-7]. These longer Aβs show an increased 
propensity to form oligomers, which can assemble into large extracellular deposits, the amyloid 
plaques, a characteristic feature of AD. Aβ42/Aβ43 oligomers are now considered as the toxic, 
AD initiating elements rather than the more prominent plaques initially discovered by Aloïs 
Alzheimer. This ‘amyloid cascade theory’ is further supported by the identification of the 
genetic causes of early onset familial AD (FAD). These rare forms of AD (less than 1% of all 
AD cases) are indeed all associated with specific mutations of either AβPP or PS1 or PS2 genes 
(the clatter encodes for the catalytic subunits of the γ-secretase complex) [review in 8, 9]. In 
addition, a specific, protective mutation of AβPP was recently found to be associated with 
reduced risk for developing AD [10]. Furthermore, animal models that express mutated forms 
of AβPP and/or PS1, or human Aβ42/Aβ43, develop molecular, cellular and cognitive deficits 
reminiscent of AD [6, review in 11, 12]. Yet, the level of the different forms of Aβs is not well 
correlated with cognitive deficits in mice, suggesting that Aβs may represent markers rather 
than inducers of AD in these models [13]. An altered processing of γ-secretase substrates other 
than AβPP might also be important in the pathogenesis of AD. Although FAD is clearly a 
consequence of genetic mutations of genes encoding the proteins responsible for the production 
of Aβs, the initial trigger(s) of late-onset, sporadic AD (>99% of AD cases) remain unknown, 




despites extensive genome-wide association studies (GWAS) and the identification of various 
risk factors [review in 14].  
Environmental neurotoxic agents including pesticides, organic solvents, metals and 
some natural toxins (cyanobacteria) are likely sources of AD-inducing factors [reviews in 15-
25]. According to the US Environmental Protection Agency (EPA) Toxic Substances Control 
Act, over 84,000 chemicals are manufactured or imported at levels >10 tons per year, not 
including pesticides, cosmetics, food stuffs and food additives which are covered by other 
legislations (www.epa.gov). It is estimated that we are exposed to over 85,000 substances 
which, along with all natural substances to which we are exposed from conception to death, 
constitute the ‘human chemical exposome’ (HCE) [26-34]. In search for such potential 
“Alzheimerogens” (named by analogy with carcinogens), and encouraged by the discovery of 
Aftins (Amyloid β Forty-Two Inducers) [35-37], a class of synthetic compounds which 
specifically induce the production of Aβ42, we have started to assemble and screen a library of 
compounds belonging to the HCE for Aβ42-inducing products. Our first study identified some 
triazine herbicides as products stimulating the production of Aβ42/Aβ43 in numerous cell lines 
[38]. 
 In this new study, we show that several members of the pyrazole class of insecticides, 
exemplified by fipronil, also increase the γ-secretase-dependent production of Aβ42/Aβ43 
peptides in various cell lines and in a cell-free system with highly purified -secretase. 
Interestingly fipronil is metabolized to fipronil sulfone, a very persistent product that 
accumulates in adipose tissue and brain. These results show that the HCE contains various brain 
permeable products able to induce the production of pathogenic Aβs. If long exposures occur 
in real life and if accumulation of Aβ42/Aβ43 is sufficient to trigger 
neurodegeneration/neuroinflammation, such products may contribute to the initiation, 
development and acceleration of sporadic AD and might thus be collectively qualified as 
potential “Alzheimerogens”. Some of them might also be used to develop useful pesticide-
induced animal models of AD. 
 
MATERIAL AND METHODS 
Material and methods are described in full in the Supplementary Information (SI) 
section. They include: 1. Pyrazoles and other reagents. 2. Cell cultures: cell lines, iPSCs-derived 
neurons & HEK293-alcadeinα cells. 3. Purified γ-secretase preparation. 4. Aβ cell-based and 
cell-free assays. 5. Cell viability. 6. Pharmacokinetics studies. 7. Proteomics study.  





Screening HCE compounds reveals pyrazole insecticides as Aβ42 inducers 
We first screened a library of over 3500 low molecular weight compounds 
representative of the HCE for their ability to induce the production and secretion of Aβ42 by 
N2a cells stably expressing AβPP695 (N2a-AβPP695). An MTS-based cell viability assay was 
run in parallel to assess cell survival. Although the vast majority of compounds were unable to 
induce Aβ42 production, a few active products including several triazine herbicides [38] and 
pyrazole insecticides (this article) were identified. We next assembled a small library of 18 
pyrazoles (1-18, SI, Tables S1, S2) that we further tested, along with aftin-5 (19) as a positive 
control, for their ability to trigger Aβ42 production at 5, 10, 25 or 50 µM, in both N2a and CHO 
cells stably expressing AβPP695 and AβPP751, respectively (SI, Table S2) (Fig. 1). Nine 
pyrazoles were found to induce more than a 3-fold change in Aβ42 levels, showing that Aβ42 
induction is an intrinsic property of some, but not all, pyrazoles: fenpyroximate (2), 
tebufenpyrad (3), bixafen (4), fluxapyroxad (5), isopyrazam (6), penthiopyrad (8), 
chlorantraniliprole (14), tolfenpyrad (16) and fipronil (18) (Fig. 1, 2). We next focused on 
fipronil (18) 1, a widely produced insecticide used to treat crops and pet parasites [reviews in 
39-44], and we assembled a small library of fipronil analogues and metabolites (Fig. 3) which 
were tested for their Aβ42 production ability in N2a-AβPP695 cells (SI, Table S3). The two 
fipronil enantiomers (18a, 18b) were separated by SFC chiral chromatography (Regis Whelk 
O1 SS column) and found to be roughly equipotent. Interestingly the main metabolites of 
fipronil (18) [45], fipronil sulfone (20), fipronil desulfinyl (21) and fipronil sulfide (22) 
displayed Aβ42 inducing activity equivalent or close to that of the parent compound. In contrast, 
a few other environmental metabolites such as fipronil chloramine (24) [46] and hydroxy-
fipronil (25) [47] were found to be inactive (SI, Table S3). 
Aβ42 production triggered by pyrazoles in N2a-APP695 cells requires β- and γ-secretase 
activity as demonstrated by the fact that it was strongly inhibited by β- (inhibitor IV) and γ-
secretases (BMS 299897, DAPT) inhibitors and by a γ-secretase modulator (‘Torrey Pines’ 
compound, inducing an increase in Aβ38 and a decrease in Aβ42 and Aβ40) [48, 49] (Fig. 4). Aβ38 
                                                          
1 Although fipronil is not the most potent Aβ42 inducer, it was selected for more detailed studies, among other 
pyrazoles, for several reasons: (1) its very wide use all over the world (despite its ban in Europe in America for 
food plant cultures), (2) its wide use against fleas and ticks in domestic animals, (3) its wide presence in urban and 
rural environment, (4) its chemical stability and environmental persistence (especially that of its metabolite, 
fipronil sulfone), (5) the biological activity of the main metabolite, (6) the fact fipronil sulfone accumulates in 
adipose tissue, crosses the blood brain barrier and accumulates in the brain, (8) its availability in large quantities 
for very cheap prices (in preparation of our current long term exposure experiments the supply issue needed to be 
solved). Incidentally, fipronil was selected before the public health scandal of summer 2017 in Europe! 




production was also strongly reduced following pyrazole treatment, while Aβ40 levels were only 
modestly affected, as measured by ELISA (data not shown) and by mass spectrometry (Fig. 5). 
Increased Aβ42 production triggered by pyrazoles was further confirmed in HEK293 cells stably 
expressing AβPPsw (data not shown) and neurons derived from human iPSCs (see below).  
 
Mass spectrometric quantification and profile analysis of pyrazole-induced Aβs  
Aβ38, Aβ40 and Aβ42 were quantified in N2a-AβPP695 cell culture supernatants using LC-
MS/MS [50, 51]. Like aftins [35, 36] and triazines [38], pyrazoles induced a reduction in Aβ38 
levels, a slight increase in Aβ40 levels and a strong increase in Aβ42 levels (Fig. 5).  
We next analyzed, by IP-MS [52], the profile of Aβs produced by N2a-AβPP695 exposed 
to fipronil (18), fipronil sulfone (20) and fipronil desulfinyl (21) (Fig. 6). Cell supernatants were 
collected and Aβs were immunoprecipitated and analyzed using MALDI-TOF/TOF [52] (Fig. 
6). Exposure to pyrazoles decreased the production of Aβ1-18, Aβ1-19, Aβ1-33, Aβ1-37 and Aβ1-38. 
Aβ1-40 levels showed a modest increase. In contrast, the two highly neurotoxic [6, 7, 53-55] 
amyloid peptides Aβ1-42 and Aβ1-43, which were undetectable in supernatants of control cells, 
were strongly induced in cells treated with fipronil (18) and its two metabolites.  
 
Neurons differentiated from human iPSCs of AD patient and healthy control 
We next tested the effects of the active pyrazoles and aftin-5 on neurons differentiated for 
4 weeks from human iPSCs derived from a healthy individual (AβPP WT, wild-type) or from 
a patient with familial AD (AβPP K724N mutation) [56-58] (Fig. 7). AβPP K724N neurons 
produced more Aβ42 versus Aβ40 compared to AβPP WT neurons. As observed with triazines 
[38], addition of any of the active pyrazoles or aftin-5 resulted in further increase in Aβ42 
production, in both AβPP WT and AβPP K724N neurons (Fig. 7). 
 
Pyrazoles affect the specificity of APP-C99 cleavage and Aβ production in a cell-free γ-
secretase activity assay  
In order to assess whether the pyrazole-based compounds modulate Aβ production 
through a direct effect on the specific processing of APP-C99 by the γ-secretase complex, we 
tested fipronil (18), fipronil sulfone (20) and fipronil desulfinyl (21) in a previously described 
cell-free activity assay performed with highly purified -secretase protease and APP-C99 
substrate (a recombinant APP C-terminal fragment expressed in Escherichia coli as a fusion 
protein consisting of a N-terminal Met for translation initiation, amino acids 597- 695 of the 




695-amino acid human isoform of APP, and a C-terminal Flag tag sequence) [59, 60]. More 
specifically, Aβs generated by purified -secretase in the presence of 100 µM of the pyrazole 
compounds were analyzed by immunoprecipitation and MALDI-TOF (IP/MS), as previously 
described [60]. We found that all three pyrazole compounds increased the Aβ42/Aβ40 ratio when 
compared to the DMSO control (Fig. 8). Importantly, our analysis further revealed that fipronil 
sulfone (20), but not fipronil (18) or fipronil desulfinyl (21), drastically increased the Aβ43/Aβ40 
ratio by ~2-fold when compared to the DMSO control (Fig. 8). These results strongly support 
the increased Aβ43 production seen exclusively with fipronil sulfone (20) in N2a-AβPP695 cells 
(Fig. 6). Altogether, we found that pyrazoles favor the production of the toxic Aβ42 and/or Aβ43 
peptides, both of which contribute to the formation of amyloid plaques and the development of 
AD. 
 
Pyrazoles shift the cleavage pattern of another γ-secretase substrate, alcadeinα 
Like AβPP, alcadeins (Alcs) are sequentially cleaved by secretases, first by α-secretase, 
leading to N- and C-terminal fragments, the latter being then cleaved by γ-secretase to an 
intracellular domain and the p3-Alcs peptide, in a way similar to AβPP [61, 62] (see Fig. 6A in 
Ref. 38]. HEK293 cells stably expressing full length alcadeinα were used to investigate the 
effects of pyrazoles on alcadein cleavage. Alcadeinα is first cleaved on the N-terminal side (two 
possible sites) followed by cleavage by γ-secretase leading to p3-Alcα35 and p3-Alcα 2N+35, 
the latter representing the major peptide in cultured cells. HEK293-alcadeinα cells were grown 
till 70% confluence and treated with 100 µM pyrazoles for 48 h. The secreted p3-Alcα peptides 
were recovered by immunoprecipitation and analyzed by MALDI TOF/MS (Fig. 9A). 
Quantification of p3-Alcα peptides showed that, compared to the p3-Alcα peptide profile in 
vehicle treated cells, concentrations of the main alcadeinα peptide (p3-Alcα2N+35) and p3-
Alcα2N+37 peptide remained stable. In contrast, both p3-Alcα2N+34 and p3-Alcα2N+36 
concentrations dropped significantly while the level of p p3-Alcα2N+38 peptide concentration 
strongly increased (Fig. 9B). These results show that, like for AβPP, pyrazoles induce a shift in 
the cleavage pattern of Alcadeinα, another γ-secretase substrate. Similar effects were seen 
previously with aftin-5 and triazines [38]. These observations further suggest that pyrazoles are 
more likely to interact with γ-secretase than with their substrates. 
 
Proteomics study of fipronil’s effects 
In order to understand the molecular mechanisms of action of pyrazoles, we decided to 
analyze protein expression of cells exposed to fipronil sulfone (20) and dipropetryn, two 




structurally unrelated products which, despite their unidentified targets, share the property of 
inducing Aβ42 production. N2a-AβPP cells were exposed for 18 h to 20 µM fipronil sulfone 
(20), 100 µM dipropetryn or 0.1% DMSO (control) and processed cells for proteomics analysis. 
Cell supernatant Aβ42 levels were increased as expected (data not shown). A total of 8,027 
proteins were identified in the multiplex experiment (data not shown). The expression of 1,634 
and 1,638 proteins was modified, respectively, in fipronil sulfone (20)- and dipropetryn-treated 
cells compared to control, DMSO-treated cells (Fig. 10A). Among these, 261 proteins were 
shared by both products-treated cells, out of which 178 were up-regulated or down-regulated in 
the same direction for both products (SI, Table S4). DAVID analysis of these 178 proteins 
showed that they gather in mitochondrial pathways, cell cycle control, AD (Fig. 10B)  
 
Fipronil is metabolized to fipronil sulfone, a stable metabolite which accumulates in 
adipose tissue and brain 
We next investigated the pharmacokinetics and biodistribution of fipronil (18) and its 
metabolites in mice (Fig. 11) and rats (SI, Fig. S2). Mice first received a single oral dose of 
fipronil (18) and blood, brain and adipose tissue were collected at various times during 72 h 
(Fig. 11). Plasma pharmacokinetics showed rapid elimination of fipronil (18) and parallel 
appearance of fipronil sulfone (20) which remained stable during the 72 h time-course (SI, Fig. 
S1). No fipronil desulfinyl (21) was detected. Similarly, fipronil (18) transiently appeared in 
brain and adipose tissues, while fipronil sulfone (20) accumulated to a stable level in both 
tissues (Fig. 11A, 11B). Fipronil sulfone (20) reached a 5-6 fold higher concentration in adipose 
tissue compared to brain. Given the metabolic stability of fipronil sulfone (20), we next ran a 
two months duration study following a single oral administration of fipronil (18) (Fig. 12A). 
Fipronil sulfone (20) levels were determined at various times up to 56 days after the single 
administration. The half-life of fipronil sulfone (20) was found to be 14 + 3 days, 17 + 2 days 
and 26 + 3 days in plasma, brain and adipose tissue, respectively (Fig. 11A). We next 
administered fipronil (18) daily, 5 days/week for 3 weeks and measured fipronil sulfone (20) in 
plasma, brain and adipose tissue (Fig. 12B). This repeated oral dosing allowed the maintenance 
of a stable level of fipronil sulfone (20) in plasma, brain and adipose tissue (Fig. 12B). 
Pharmacokinetics and biodistribution of fipronil (18) and fipronil sulfone (20) were next studied 
in rats during a 14 days period, following a single oral administration. Results confirmed rapid 
metabolism of fipronil (18) to fipronil sulfone (20) (SI, Fig. S2A). Fipronil sulfone (20) was 
much more stable and showed extensive accumulation in adipose tissue (peak concentration 48 









This study reports on the induction of Aβ42/Aβ43 production, and the increased ratio of 
long vs. short Aβs, in various cell cultures and by highly purified γ-secretase following exposure 
to several pyrazole insecticides. These results support previous results obtained with various 
drugs (fenofibrate, celecoxib, indomethacin, isoprenoids) [63], DAPT under certain conditions 
[64, 65], steroids [66], ceramide analogs [67], the peroxynitrite donor SIN-1 [68], Zinc [60], 
aftins [35-37] and several triazine herbicides [38]. Altogether these results have two main 
implications: 
(1) they support the idea that the HCE contains several compounds able to shift the cleavage of 
AβPP towards the production of long, toxic, aggregation-prone Aβs, such as Aβ42/Aβ43, those 
which are classically associated with AD in humans and numerous animal models of AD. These 
compounds, if proven to modify this balance in animals (as suggested by the first preliminary 
results obtained with aftin-4 [28] and celecoxib or FT-1 [63]) and in human, may contribute to 
the onset, development and/or acceleration of AD. We suggest that they be collectively named 
“Alzheimerogens”, by analogy with cancer-inducing carcinogens. Identification of such 
compounds in our environment appears to be a priority to develop a prevention strategy. 
(2) some of these compounds, particularly the metabolically stable, brain-permeable molecules, 
constitute new pharmacological research tools to investigate the role of γ-secretase, its 
substrates and products, in the onset of AD, in cell lines and animal models. In this context, one 
of our objectives is, by analogy with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-
induced Parkinsonism, to develop a pesticide-induced animal model of AD, which would allow 
the study of AD onset in wild-type (WT) animals. This is exemplified by the orally available 
fipronil (18) which is rapidly metabolized to fipronil sulfone (20), a very stable compound 
which accumulates in adipose tissue, crosses the blood brain barrier and reaches stable levels 
in the brain (Fig. 11, 12; SI, Fig. S2). We are currently running long-term exposure experiments 
with fipronil (18) administered orally in WT mice and Tg2576 mice (overexpressing isoform 
695 of human AβPP with the Swedish mutation (KM670/671NL)). 
 
Mechanism of action of fipronil and other pyrazoles 




 As also observed with aftins [36] and triazines [38], pyrazoles insecticides, including 
fipronil derivatives, show a structure/activity relationship (SI, Table S1) in their effects on Aβ 
production - some are active, others are inactive -, showing that pyrazole insecticides devoid of 
Aβ42 induction properties can be developed. The limited number of pyrazoles and their wide 
structural diversity precludes a clear identification of key structural features interacting with the 
unknown target leading to Aβ42 production. Unspecific, detergent, hydrophobic, membrane or 
protein structure disrupting actions are unlikely to account for the effects of pyrazoles. Several 
arguments support an effect on γ-secretase and/or its micro-environment: 
(1) induction of Aβ production by pyrazoles is inhibited by γ-secretase inhibitors or modulators 
(Fig. 4), 
(2) pyrazoles also affect the cleavage of another substrate of γ-secretase, alcadeins (Fig. 10), 
(3) pyrazoles modify the cleavage pattern of AβPP by highly purified γ-secretase. 
Our cell-free γ-secretase activity assays performed with highly purified enzyme and 
substrate (Fig. 8) show that fipronil (18), Fipronil sulfone (20) and fipronil desulfinyl (21) 
clearly increased the Aβ42/Aβ40 ratio. Remarkably, Fipronil sulfone (20) additionally increased 
by ~2-fold the Aβ43/Aβ40 ratio. At the molecular level, the γ-secretase complex cleaves the 
APP-C99 substrate within the transmembrane domain (TMD), first at the ε-site located at the 
intracellular interface, to generate two different C-terminal APP intracellular domains (AICDs) 
of 50 or 51 aa length [69]. To generate Aβs of different lengths, γ-secretase next cleaves the N-
terminus of the TMD every α-helical turn (corresponding to 3-4 amino acids), starting from ε-
sites, following two production lines: the AICD51/Aβ48 pathway (Aβ48Aβ45Aβ42Aβ38) 
and the AICD50/Aβ49 pathway (Aβ49Aβ46Aβ43Aβ40) [69]. Consistent with a direct effect 
of pyrazoles on APP-C99 processing, our results support an altered Aβ48 pathway leading to an 
increased Aβ42 production. Surprisingly, our study further revealed that fipronil sulfone (20) 
unambiguously and drastically increases the Aβ43/Aβ40 ratio (Fig. 8). This observation is 
important since Aβ43 is known to be highly amyloidogenic and a main species involved in the 
formation of senile plaques [6, 7, 70]. As of today, Aβ43 is known to be a direct precursor of 
Aβ40 [69]. Therefore, the increased Aβ43 production in the cell-free assay suggests that fipronil 
sulfone (20) blocks the processing of APP-C99 at position 43 in the Aβ49 pathway, an event 
which is likely associated with reduced Aβ40 production. 
Further quantitative experiments are required to explain the increased Aβ42/Aβ40 or 
Aβ43/Aβ40 ratios, caused either by increased Aβ42 or Aβ43 production, a reduced Aβ40 
production or both. In any case, an altered Aβ profile in the presence of pyrazole insecticides 
strongly suggests that the compounds directly affect the positioning of the AβPP substrate in 




the lipid-bilayer, as previously observed for compounds known as inverse γ-secretase 
modulators (iGSM) [64]. Similarly to what we observed with fipronil (18) and fipronil 
desulfinyl (21), the iGSM nonsteroidal anti-inflammatory drugs (NSAIDs) Fenofibrate and 
Celecoxib have indeed been reported to be Aβ42-raising and Aβ38-lowering compounds [63]. 
Interestingly, Celecoxib is a pyrazole. The pyrazole scaffold has in fact been used extensively 
in therapeutic drug development [review in 71]. In contrast to iGSMs, some NSAID-based γ-
secretase modulators (GSM), including sulindac-sulfide, lower Aβ42 and increase Aβ38 
productions [63]. GSMs are of great pharmaceutical interest and are currently under clinical 
evaluation for their ability to reduce the production of the amyloidogenic Aβ42 and Aβ43 
peptides. At the same time the potential risk from Aβ42 and Aβ43 producing iGSMs needs careful 
evaluation since some of these compounds are FDA-approved and widely used as NSAIDs. At 
the molecular level, it has further been shown that residues 29–36 (GAIIGLMV) of the Aβ 
motif in APP-C99 located at the TMD N-terminus represent the binding site of both Aβ42-
lowering GSMs and Aβ42-raising iGSMs [63]. This raises the question whether the same 
binding site could be involved in the pyrazole-induced Aβ42/Aβ40 and Aβ43/Aβ40 ratio increase. 
Interestingly, we recently found that zinc can drastically raise the Aβ43/Aβ40 ratio by influencing 
the positioning of the APP-C99 TMD through binding to Lysine 28, which is located at the 
surface of the membrane and is involved in anchoring APP-C99 in the lipid bilayer [69]. This 
observation further supports the possibility that Lys28 and more globally residues 29–36 in 
APP-C99 are involved into the pyrazole-induced Aβ43/Aβ40 increase. Finally, novel GSMs have 
recently been reported that directly bind on PS1 [72]. Binding of these compounds to PS1 
induced a conformational change in the enzyme-substrate interaction that modulated the 
protease activity and consequently the Aβ profile. Thus, one cannot exclude that fipronil (18), 
fipronil sulfone (20) or fipronil desulfinyl (21) also modulate APP-processing by directly 
binding to the γ-secretase complex. Further experiments are needed to decipher the mode of 
action of these compounds (see SI, Fig. S3 for working model).  
 
Fipronil exposure and consequences 
 Fipronil has been developed a selective inhibitor of insect GABA-gated chloride 
channels [review in 44]. It is one of the most widely used pyrazole insecticides in agriculture 
(seed, culture & crop treatment), in urban pest control (coackroaches, termites, wasps, flies & 
ants management in & around buildings) and in veterinary applications (fleas & ticks control 
for pets and cattle). Fipronil and its metabolites are therefore widely found [73] in urban soil, 
dust, wastewater and residential runoff [74], in rural soil, rivers and atmosphere [46, 73, 75, 




76], but also in various tissues of pet, farmland and wild-life animals [75, 77, 78] (only a very 
small number of references are cited). Although fipronil (18) is relatively resistant to 
degradation, it is mostly oxidized to fipronil sulfone (20), reduced to fipronil sulfide (22), 
photodegradated to fipronil desulfinyl (21), hydrolyzed to fipronil amide (23, 28). Many other 
metabolites have been described [45-47, 73, review in 39]. Although fipronil shows low affinity 
for mammalian GABA-gated chloride channels compared to those of insects, toxicity studies 
carried out with fipronil and its metabolites in various vertebrates [39, 40, 43, 44, 77] as well 
as studies performed with mammalian cells studies [79-83] cast some doubts about the safety 
of fipronil to humans (see SI, Table S5). This concern is amplified by (1) the existence of 
numerous metabolites which are poorly characterized in terms of toxicity, (2) their long 
persistence in the environment (soil, water, sediment and atmosphere), (3) their accumulation 
in tissues, especially adipose tissue (Fig. 11, 12), (4) the potency of fipronil sulfone on 
mammalian GABA-receptor [84], (5) the fact that fipronil and its metabolites essentially meet 
all druggability criteria of Lipinski’s rule of Five (SI, Table S6). In addition, fipronil (along 
with neonicotinoids) is a major worldwide concern for the survival of pollinators [85-89]. In 
mammals, fipronil shows oxidative stress, neurotoxic, thyroid, endocrine, lung inflammation, 
blood pressure and reproductive effects [review in 44] at high doses. In humans, fipronil triggers 
mild nervous troubles as seen in acute intoxication cases [90, 91] and apparently impacted 
thyroid functions of workers following occupational exposure [92]. 
 As shown in Fig. 11 & 12, fipronil (18) is rapidly metabolized to a very stable product, 
fipronil sulfone (20), which readily accumulates in fat tissue. Table 1 reviews plasma and tissue 
levels of fipronil sulfone (20) reached experimentally in mice and rat or accidentally in humans 
(our data + literature data). The highest plasma levels reached experimentally during these 
relatively short exposures (3.7 µg/mL, i.e. 8.2 µM) are not very far from those which induce 
Aβ42 and Aβ43 production. Adipose tissue and brain levels reached experimentally are probably 
higher. 72 h after a single oral administration of 14C-fipronil to rats, about 50% and 2% of the 
radioactivity (essentially fipronil sulfone) were found in adipose tissue and brain, respectively 
[93]. Fipronil sulfone is also the primary metabolite produced in human via hepatocyte 
cytochrome P-450 oxydation [90, 92-95]. Fipronil sulfone was detected in about 25% of 96 
human serum samples (0.1-39 ng/mL which corresponds to 0.22-86 nM) [45]. These samples 
were obtained from individuals with no known fipronil exposure. However fipronil applied to 
the fur of pets is easily and rapidly transferred to humans [96, 97]. Fipronil and fipronil sulfone 
levels were measured in urine and blood samples of 159 workers in a factory manufacturing 
fipronil-containing veterinary products [92]: 33 and 155 had detectable serum fipronil and 




fipronil sulfone (0.37-42.45 ng/mL, i.e. 0.82-9.32 nM), respectively. Incidentally, fipronil has 
recently been shown to promote adipogenesis [98] and adiposity/obesity has been suggested as 
a risk factor for AD [99, 100]. Adipose tissue may thus act as a trap and storage tissue for 
lipophilic, Aβ42/Aβ43 inducers like fipronil, other pyrazoles, other pesticides. The persistence 
of fipronil sulfone, its accumulation in adipose tissue, and its ability to enter the brain raises 
concerns on its possible long term effects on the central nervous system, in particular on its 
possible effects on the production of toxic, aggregation-prone amyloidogenic Aβ42 and Aβ43, as 
shown in this article.  
 In conclusion, we have added some pyrazole insecticides, especially the main metabolite 
of fipronil, in the growing list of HCE products which are able to alter the specificity of Aβ 
production. Our hypothesis is that these products may, on a long-term, cumulative and additive 
basis, possibly in parallel with microorganisms [101] and microorganisms-derived products, 
alter the Aβ production pattern sufficiently to lead to AD pathogenesis, and thus qualify as 
“Alzheimerogens”. Gradual accumulation in and chronic release from adipose tissue and 
transfer to the brain may contribute to the onset, development and acceleration of sporadic AD. 
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Table 1. Concentrations of fipronil sulfone reached in mammals following fipronil 
administration (oral, ip, iv, general exposure). Fipronil sulfone (20) levels are expressed 
either in µg/mL or in µg/g. A 4.53 µg/mL concentration is equivalent to a concentration of 10 
µM. bw, body weight. 
 
Species/tissue Exposure conditions Fipronil sulfone (20) levels reached Refs. 
Mouse    
plasma 10 mg/kg bw, oral, single administration 1 - 1.1 µg/mL Fig. 11, 12A 
plasma 10 mg/kg bw, oral, 5 days/week/3 weeks 3.7 µg/mL Fig. 12B 
plasma 2.5 or 10 mg/kg bw, oral, 1 day/week/2 weeks 0.029 or 0.210 µg/mL  SK, unpubl. 
plasma 2.5 or 10 mg/kg bw, oral, 3 days/week/2 weeks 0.211 or 0.662 µg/mL  SK, unpubl. 
adipose tissue  2 mg/kg bw, ip, daily/6 days 22-24 ppm [102] 
adipose tissue 10 mg/kg bw, oral, single administration 4.3 - 4.9 µg/epididymal adipose pad Fig. 11, 12A 
adipose tissue 10 mg/kg bw, oral, 5 days/ week/3 weeks 13.5 µg/epididymal adipose pad Fig. 12B 
adipose tissue 2.5 or 10 mg/kg bw, oral, 1 day/week/2 weeks 0.730 or 5.276 µg/g  SK, unpubl. 
adipose tissue 2.5 or 10 mg/kg bw, oral, 3 days/week/2 weeks 6.098 or 12.48 µg/g SK, unpubl. 
brain 40 mg/kg bw, ip, 6 or 20 min, single administration 19 or 32 ppm (6 and 20 min, respectively) [103] 
brain 10 mg/kg bw, oral, single administration 0.71 - 0.75 µg/brain Fig. 11, 12A 
brain 10 mg/kg bw, oral, 5 days/week/3 weeks 2.7 µg/brain Fig. 12B 
brain 2.5 or 10 mg/kg bw, oral, 1 day/week/2 weeks 0.049 or 0.405 µg/g  SK, unpubl. 
brain 2.5 or 10 mg/kg bw, oral, 3 days/week/2 weeks 0.585 or 1.746 µg/g  SK, unpubl. 
Rat    
plasma 10 mg/kg bw, oral, single administration 1.4 µg/mL Fig. S1 
plasma 5 or 10 mg/kg bw, oral, daily/2 weeks 2.4 or 3.6 µg/mL [104] 
plasma 30 mg Regent ®/kg bw, oral, daily/15 days 0.46 µg/mL [105] 
plasma 4 µg/kg bw, oral, 3X/ week/90 days 0.008 - 0.39 ng/mL [106] 
plasma 3.4 (po) or 6.9 (iv) µmole/kg bw, single administration 0.2 (po) or 0.25 (iv) µg/mL [107] 
plasma 3.4 µmole/kg bw, oral, daily/14 days 1.5 µg/mL [107] 
plasma 3 mg/kg bw, oral, daily/13 days 0.043 – 2.8 µg/mL [108] 
adipose tissue 10 mg/kg bw, oral, single administration 152.3 µg/g Fig. S3 
adipose tissue  10 mg/kg bw, oral, 72 h, administration 47.87 µg fipronil equivalent (>90% 
fipronil sulfone)/g wet weight  
[93] 
brain 10 mg/kg bw, oral, single dose 3.74 µg/g Fig. S2 
urine 5 or 10 mg/kg bw, oral, daily/2 weeks or single dose 0.023-0.026 µg/mL [47] 
urine 5 or 10 mg/kg bw, oral, daily/2 weeks 0.024 or 0.032 µg/mL [104] 
urine 4 µg/kg bw, oral, 3X/week/90 days 0.009-4.27 ng/mL [106] 
hair 4 µg/kg bw, oral, 3X/week/90 days 4.58-306 pg/mg [106] 
Human    
plasma no known fipronil exposure (96 plasma samples) 0.1-3.9 ng/mL; detected in 25% of the 
samples.  
[104] 
plasma conducted on 159 workers from a factory 
manufacturing fipronil-containing veterinary products 
in France 
mean: 7.79 ng/mL  
(range: 0.37-42.45 ng/mL) 
detected in 155 out of 159 workers.  
[92] 
plasma 6 cases of self-poisoning with Regent ® 
 
maximum fipronil + fipronil sulfone level 
measured was 3.74 µg/mL 
[109] 
urine no known fipronil exposure (84 urine samples) undetectable [104] 
 
  






Figure 1. Some pyrazoles trigger the production of extracellular amyloid Aβ-42. Effect of 
18 pyrazoles on extracellular amyloid Aβ42 production by N2a-APP695 and CHO-7PA2-
APPsw cells. Cells were treated with 100 µM of each compound for 18 h and cell supernatants 
were collected for extracellular Aβ42 levels measurement by an ELISA assay. Aftin-5 was used 
as a positive control and the corresponding volume of vehicle (DMSO) was used as a negative 
control. Levels are expressed as fold change, + standard error (SE), of Aβ42 levels over the 
Aβ42 level of control, vehicle-treated cells. Average of five experiments performed in triplicate. 
Horizontal dotted lines indicate levels for 1- and 3- fold increases in Aβ42 concentration.  
 
Figure 2. Molecular structure of the nine active pyrazoles. 
 
Figure 3. Molecular structure of fipronil and some of its metabolites and derivatives. 
 
Figure 4. Extracellular Aβ42 production induced by pyrazoles is inhibited by β-secretase 
inhibitor IV, γ-secretase inhibitors DAPT & BMS 299897, and γ-secretase modulator 
'Torrey Pines'. N2a-APP695 cells were exposed to 10 µM β-secretase inhibitor IV, 2 µM BMS 
299897, 2 µM DAPT or 10 µM 'Torrey Pines' compound. 1.5 h later cells were exposed to 50 
µM (2, 5, 8, 14, 16, 18) or 25 µM (3, 4, 6) pyrazoles or 50 µM aftin-5. Extracellular Aβ42 levels 
were measured after 18 h and are expressed as fold change, + standard error, of Aβ42 level in 
pyrazole-treated cells over the Aβ42 level of control, vehicle-treated cells. Representative of two 
independent experiments performed in triplicates. Errors bars represent SE of all six values. 
 
Figure 5. Absolute quantification of Aβ38, Aβ40 and Aβ42 using LC-MS/MS. Levels of the 
three Aβs were determined by mass spectrometry in supernatants of N2a-APP695 cells 
following 18 h treatment with DMSO, 100 µM of pyrazoles 18, 20 or 21. Amyloid levels are 
expressed as percentage of levels in vehicle-treated cells (average + SE of quadriplicate values; 
absolute values in control cell supernatants are indicated) and Aβ42/Aβ40 ratios are indicated in 
parentheses. Horizontal dotted line indicates basal Aβ levels vs. the values in DMSO-treated 
cells. 
 
Figure 6. Pattern of Aβs produced by N2a-APP695 cells exposed to pyrazoles 18, 20 or 21. 
Cells were treated for 18 h with DMSO or 20 µM of each pyrazole. Cell supernatants were 




collected and analyzed as described. Quantification of all Aβs in N2a-APP695 cells 
supernatants are presented as percentage of total amyloids. Note the decrease in peptides Aβ1-
37, Aβ1-38, the increase in Aβ1-40 and the appearance of Aβ1-42 and Aβ1-43 in the supernatants of 
pyrazole-treated cells (these two peptides are undetectable in the supernatant of DMSO-treated 
cells). 
 
Figure 7. Pyrazoles trigger enhanced production of Aβ42 versus Aβ40 in neurons 
differentiated from human induced pluripotent stem cells. Neurons were derived from 
iPSCs obtained from healthy donor (APP WT, white bars) or from an AD patient with APP 
K724N mutation (grey bars). They were exposed for 24 h to DMSO (control), 100 µM aftin-5 
or the nine pyrazoles. Cell supernatants were collected for extracellular Aβ40 and Aβ42 levels 
measurement by an ELISA assay. Levels are expressed as Aβ42/Aβ40 ratios + SE of triplicate 
values. Horizontal dotted line indicates level for 1-fold increase in Aβ42 concentration 
 
Figure 8. Mass spectrometric analysis of the Aβs generated in cell-free γ-secretase assays, 
in the presence of DMSO or fipronils 18, 20 or 21. A. The Aβs generated by highly purified 
γ-secretase in the presence of 100 µM of fipronil (18), fipronil sulfone (20) or fipronil desulfinyl 
(21) or DMSO (vehicle) were pooled from triplicates of the activity assays, immunoprecipitated 
overnight with the anti-Aβ antibody 4G8 and protein G and analyzed by MALDI-TOF in a 
reflectron mode. The Aβs generated from the recombinant APP-C99 contain an N-terminal 
methionine, which results in a mass shift of +149m/z when compared to endogenous Aβ 
peptides. B. Note the increased Aβ42/Aβ40 ratio for fipronils 18, 20 and 21, and the increased 
Aβ43/Aβ40 ratio for fipronil sulfone (20).  
 
Figure 9. Pyrazoles alter the cleavage pattern of Alcadeinα, leading to increased p3-
Alcα38 production. A. Immunoprecipitation/mass spectrometry spectra of p3-Alcα peptides 
produced by HEK cells expressing full length Alcadeinα exposed to various pyrazoles or 
DMSO (control). Cells were treated for 48 h with 100 µM of each reagent and p3-Alc peptides 
were analyzed by MALDI-TOF/MS. A. Representative profile for each product showing the 
the p3-Alcα2N+34, p3-Alcα2N+35, p3-Alcα2N+36, p3-Alcα2N+37 and p3-Alcα2N+38 peaks. 
B. Relative quantification of p3-Alcα peptides produced by cells exposed to DMSO (control), 
fipronil (18), fipronil sulfone (20) or fipronil desulfinyl (21). Levels of each peptide are 




presented as relative ratios of p3-Alcα2N+38 versus p3-Alcα2N+35 (average + SEM of 
triplicate values).  
 
Figure 10. Proteomics & phosphoproteomics analysis of N2a-APP695 cells exposed to 
fipronil sulfone (20)- and dipropetryn- treated cells. A. N2a-APP695 cells were exposed for 
18 h to 20 µM fipronil sulfone (20), 100 µM dipropetryn or DMSO. This led to increased 
extracellular Aβ42 expression (3.58 + 0.05 and 7.87 + 0.81 fold change for fipronil sulfone (20) 
and dipropetryn, respectively, compared to DMSO-treated cells). Up/down-regulated proteins 
in fipronil sulfone- (1634) and dipropetryn- (1638) treated cells vs. DMSO-treated cells were 
identified and compared. Among the 261 common proteins, 178 proteins (listed in 
Supplementary Table S1) were either up-regulated by both treatments or down-regulated by 
both treatments. B. DAVID analysis of the 178 proteins common to fipronil sulfone (20) and 
dipropetryn treatments. Data are selected with p-value <0.01 and FDR <0.05. FDR = False 
Discovery Rate. 
 
Figure 11. Short-term time-course of fipronil (18) and fipronil sulfone (20) 
bioaccumulation in brain (A) and epididymal adipose tissue (B) following a single oral 
administration of fipronil (18). Fipronil (18) (10 mg/kg) was administrated by oral gavage at 
time 0. Animals were sacrificed at various times and plasma, epididymal adipose tissue and 
brain were collected. Fipronil (18) and fipronil sulfone (20) levels were quantified by LC-
MS/MS. Concentrations are expressed as µg/brain or µg/epididymal adipose tissue. 
 
Figure 12. Long-term time-course of fipronil sulfone (20) production and accumulation 
following single (A) or repeated (B) oral administrations of fipronil (18). A. Fipronil (18) 
(10 mg/kg) was administrated by oral gavage on day 0. Animals were sacrificed at various times 
and plasma, epididymal adipose tissue and brain were collected. Fipronil sulfone (20) levels 
were quantified by LC-MS/MS. B. Fipronil (18) (10 mg/kg) was administrated by oral gavage 
5 days /week for 3 weeks (times of administration are indicated by black dots). Animals were 
sacrificed at various times and plasma, epididymal adipose tissue and brain were collected. 
Fipronil sulfone (20) levels were quantified by LC-MS/MS. Concentrations are expressed as 
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Aβ-38:  123.6 + 16.4 pg/mL 
Aβ-40:  662.0 + 90.6 pg/mL 



























































































Aβ42 / Aβ40 Aβ43 / Aβ40 
DMSO 1.00 1.00 
Fipronil (18) 1.23 1.13 
Fipronil  sulfone (20) 1.76 2.15 
Fipronil  desulfinyl(21) 1.45 1.10 
A 
B 




























































































































































Pathways (from KEGG) Genes  % p-value FDR 
Non-alcoholic fatty liver disease  20 11.3 1.9E-16 2.7E-13 
Oxidative phosphorylation 17 9.6 1.4E-13 1.7E-10 
Parkinson's disease 17 9.6 4.2E-13 5.1E-10 
Huntington's disease 17 9.6 3.5E-11 4.2E-8 
Alzheimer's disease 16 9.0 7.9E-11 9.5E-8 
Metabolic pathways 31 17.5 7.2E-7 8.7E-4 
Biological processes (GOTERM) Genes  % p-value FDR 
oxidation-reduction process 25 14.1 3.8E-9 6.0E-6 
cell cycle 21 11.9 3.4E-7 5.4E-4 
regulation of cell cycle 9 5.1 5.7E-6 8.9E-3 
cell division 14 7.9 2.2E-5 3.5E-2 
mitotic nuclear division 12 6.8 2.9E-5 4.6E-2 
Cellular compartment (GOTERM) Genes  % p-value FDR 
mitochondrial respiratory chain complex I 17 9.6 3.1E-22 4.0E-19 
respiratory chain 17 9.6 1.5E-20 2.0E-17 
mitochondrion 37 20.9 2.0E-7 2.6E-4 
mitochondrial inner membrane 16 9.0 9.1E-7 1.2E-3 
Figure 11A, 11B 
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